Concepedia

Multimodal imaging based on MRI and PET reveals [18F]FLT PET as a specific and early indicator of treatment efficacy in a preclinical model of recurrent glioblastoma

Aurélien Corroyer‐Dulmont, Elodie A. Pérès, Aurélie N. Gérault, Ariel Savina, Fanny Bouquet, Didier Divoux, Jérôme Toutain, Méziane Ibazizène, Eric T. MacKenzie, Louisa Barré,

European Journal of Nuclear Medicine and Molecular Imaging · 2015 · 27 citations · 34 references

DOI

Concepts

References

34

Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21.6K citations · Full text

, , +12

Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma

Henry S. Friedman, Michael D. Prados, Patrick Y. Wen et al. · Journal of Clinical Oncology · 2009 · 2.4K citations

, , +17

Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial

Walter Taal, Hendrika M. Oosterkamp, Annemiek Walenkamp et al. · The Lancet Oncology · 2014 · 753 citations

, , +16

Predicting Treatment Response of Malignant Gliomas to Bevacizumab and Irinotecan by Imaging Proliferation With [<sup>18</sup>F] Fluorothymidine Positron Emission Tomography: A Pilot Study

Wei Chen, Sibylle Delaloye, Daniel Silverman et al. · Journal of Clinical Oncology · 2007 · 391 citations

, , +17

Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy

Kyrre E. Emblem, Kim Mouridsen, Atle Bjørnerud et al. · Nature Medicine · 2013 · 243 citations · Full text

, , +12